Simplify Propel Opportunities ETF Rating $17.60 +0.15 (+0.86%) As of 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestBuy This Stock Simplify Propel Opportunities ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.SURI Aggregate RatingModerate Buy 2.57Holdings in SURI have an aggregate rating of Moderate Buy based on 192 analyst ratings issued in the past year covering 23 companies (94.6% of the portfolio).SURI Aggregate Price Target$17.60High Prediction$17.60Average Prediction$17.60Low Prediction$17.60Holdings in SURI have an aggregate price target of $17.60 and a range of $17.60 to $17.60 covering 23 companies (94.6% of the portfolio).SURI Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy5 Buy rating(s)Moderate Buy16 Moderate Buy rating(s)Hold2 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Simplify Propel Opportunities ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 23 SURI Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings42.22%PAGPPlains GP$24.21-0.1%2.6439 of 5 stars2.33$21.90 -9.5%12Positive NewsDividend Announcement8.36%MISTMilestone Pharmaceuticals$1.88-0.8%2.63 of 5 stars2.67$7.50 298.9%6Positive News8.15%ACHVAchieve Life Sciences$4.56+3.9%1.797 of 5 stars3.00$14.67 221.6%6News CoverageUpcoming Earnings4.03%PHATPhathom Pharmaceuticals$12.60-2.1%2.8894 of 5 stars2.88$25.00 98.4%83.66%ABEOAbeona Therapeutics$5.83-2.0%2.7471 of 5 stars2.60$19.00 225.9%5News Coverage3.66%DCTHDelcath Systems$11.53+4.6%1.6232 of 5 stars2.67$22.50 95.1%6Upcoming Earnings2.60%CLDXCelldex Therapeutics$33.86+3.3%2.8122 of 5 stars2.83$46.36 36.9%122.42%OCSOculis$27.75-1.8%3.7181 of 5 stars2.75$43.86 58.0%8Upcoming Earnings2.41%CORTCorcept Therapeutics$51.37-0.5%4.3822 of 5 stars2.50$74.67 45.4%8Earnings ReportAnalyst ForecastAnalyst Revision1.80%LONAAthira Pharma$9.63+0.8%0.7624 of 5 stars2.25$10.00 3.8%4Negative News1.65%CMPSCompass Pathways$9.32-2.1%3.0303 of 5 stars2.82$20.45 119.5%11Upcoming EarningsAnalyst Forecast1.54%IVAInventiva$5.42+2.8%3.0392 of 5 stars3.10$16.56 205.5%10Gap Up1.50%KYTXKyverna Therapeutics$9.21+2.3%1.9826 of 5 stars2.60$28.67 211.3%5News CoverageUpcoming Earnings1.41%PALIPalisade Bio$1.97-7.5%1.9545 of 5 stars2.88$10.20 417.8%8News CoverageUpcoming Earnings1.30%AQSTAquestive Therapeutics$4.18-0.9%2.5645 of 5 stars3.00$8.80 110.5%8Upcoming Earnings1.28%ZVRAZevra Therapeutics$10.61+5.6%3.3803 of 5 stars2.78$23.00 116.8%9Upcoming Earnings1.14%OBIOOrchestra BioMed$4.01-0.2%3.5368 of 5 stars2.50$14.25 255.4%6Upcoming Earnings1.03%VORVor Biopharma$15.52+5.5%3.5669 of 5 stars2.69$50.56 225.7%131.02%OCULOcular Therapeutix$9.71-0.6%3.5259 of 5 stars2.79$23.78 144.9%14Trending NewsEarnings ReportGap Down0.94%EYPTEyepoint Pharmaceuticals$13.75-0.7%2.6561 of 5 stars3.00$32.20 134.2%8Upcoming Earnings0.89%SABSSAB Biotherapeutics$3.68-0.3%2.8097 of 5 stars2.63$10.50 185.3%8Upcoming Earnings0.81%TRVITrevi Therapeutics$14.66+1.9%3.1979 of 5 stars3.00$21.60 47.3%12Earnings Report0.78%UPBUpstream Bio$9.12-2.0%1.8625 of 5 stars2.60$39.00 327.6%5Positive News This page (NYSEARCA:SURI) was last updated on 5/5/2026 by MarketBeat.com Staff. From Our PartnersYour book attachedYour Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...Profits Run | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredSell 99% of Your Stocks, Do THIS Instead…Millionaire Trader Exposes: "The Single Stock Income Plan" With over 6,000 stocks on the market to choose ...The Oxford Club | SponsoredTrade this between 9:30 and 10:45 am ESTThe first 75 minutes of the trading day may be the most overlooked window for consistent opportunities.If you ...Base Camp Trading | SponsoredIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...Banyan Hill Publishing | SponsoredElon Unveils AI Passive Income Stream for Millions of AmericansDuring Tesla's last earnings call, Elon Musk outlined a new AI-driven approach he says could generate $30,000-...InvestorPlace | SponsoredInvest in SpaceX Before IPOSpaceX is already one of the most valuable private companies on Earth, and some analysts believe its valuation...NXT Wave Research | SponsoredURGENT: $2 Gold Stock With Major DiscoveryA $2 gold stock is said to quietly control what may be the largest gold deposit in the world - worth nearly $1...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Simplify Propel Opportunities ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Simplify Propel Opportunities ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SURI Stock Alerts